While higher-income individuals may manage to afford GLP-1s OOP, lower-income individuals who are more likely to be affected by obesity will face significant access barriers
We saw about a 30% increase in GLP-1 cost, and so we have direct contracted with an [online weight-loss program] to help us manage that program
Customized Facelift Procedures : Our experienced plastic surgeons tailor each facelift to address the unique needs of post-weight loss patients
Studies show that individuals with higher body mass index (BMI) are more likely to develop psoriasis, and excess weight can result in more severe of disease and worsen symptoms
In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%
Patients with diabetes have been taking older versions of GLP-1 agonists for almost 20 years